CBD for Bladder Cancer in Dogs: New Research

CBD for Bladder Cancer in Dogs
spotify badge

Research on cannabis’ impact on cancer cells has recently become more extensive. There is always more evidence demonstrating the advantages. What could be a ground-breaking relationship between cannabis and cancer treatments is just getting started. Promising new research examines the use of CBD for canine bladder cancer.

Bladder Cancer in Dogs

Bladder cancer can be caused by various factors, including genetic predisposition, infection with certain strains of papillomavirus (the same virus associated with cervical cancer), and exposure to tobacco smoke or certain pesticides.

The most common symptoms of bladder cancer are hematuria (bloody urine) and dysuria (painful urination). Hematuria occurs when the tumor blocks urine flow through the ureters into the bladder or when it erodes into one of these structures, causing blood to seep into the urine. A dog who has been urinating frequently may also exhibit these symptoms.

Dogs with bladder cancer may also lose weight without any apparent reason or have anorexia (poor appetite). These signs can occur due to increased pain experienced by the dog during urination or defecation or because of anemia resulting from blood loss caused by the tumor.

A definitive diagnosis for bladder cancer can only be made after surgery has been performed and samples were taken during surgery for pathological examination by a veterinarian.

Bladder Cancer and CBD Research

CBD’s potential to treat canine urothelial carcinoma was investigated in a promising study carried out in Canada. The effectiveness of chemotherapy administered alone as compared to chemotherapy administered along with CBD was examined in the study.

According to the findings, CBD for bladder cancer not only reduced cell viability and caused cell death in canine urothelial cells on its own, but it also performed much better when paired with chemotherapy.

This study was conducted in vitro, meaning without the involvement of a living thing. In order to determine how precisely this combination will be applied in a therapeutic environment and to be able to translate this into the human clinical setting, additional in vivo (within a living creature) research are required.

However, study is constrained due to the characteristics of cannabis and the continuous dehumanization of it by national and international governments.

Research on living things cannot be done until cannabis is de/rescheduled at the federal level (such as clinical trials on people). To lay the groundwork for clinical research when cannabis gets descheduled federally, as much preclinical work as feasible is being done at the moment.

CBD Research is Growing

The amount of research being done on the impact of cannabis on cancer cells is only expanding, and more and more studies demonstrating its advantages are coming out. More research is being done that shows cannabis (CBD, CBN, THC, and its other chemicals) has a significant impact on cancer cells and enhances current cancer treatments as time goes on and the stigma around it fades.

Although CBD is well known to cause apoptosis, halt metastasis, and benefit patients receiving chemotherapy, more and more studies are being done on the relationship between cannabis therapy and particular tumors.

Read more:




Published by Amber Drake

Dr. Drake is an award-winning author and well-known cancer specialist in her field. She is best known for her extensive research on canine cancer prevention and nutrition, her dedication to help dogs live a long, happy life, and for teaching veterinary medicine. As the CEO of Canine Companions Co., the Founder of Drake Dog Cancer Foundation and Academy, and the Co-Founder of Preferable Pups, in addition to being a respected figure in the dog world, she has earned the respect of thousands of dog lovers worldwide.

Leave a Reply